Reducing impulsive behaviour in repeat violent offenders using a Selective Serotonin Reuptake Inhibitor (Sertraline) - Pilot study.

Status

Completed

Phases

Phase 4

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12608000559314

Enrollment

Registered

2008-11-07

Start date

2007-12-01

Completion date

2009-02-28

Last updated

2021-06-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

To determine whether SSRI are effective in reducing impulsive behaviour in repeat violent offenders.

Interventions

Oral Selective Serotonin Reuptake Inhibitor 100mg daily for 3 months.

Study design

Allocation

Non-randomised trial

Intervention model

Single group

Primary purpose

Treatment

Masking

Open (masking not used)

Eligibility

Sex/Gender

Male

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

Men At least 1 prior conviction for violence Score over 70 on an impulsivity screener

Exclusion criteria

Current medications include a Selective Serotonin Reuptake Inhibitor (SSRI) or other antidepressant (especially a Mono Amine Oxidase Inhibitor) or anti-psychotics. Severe mental illness. History of adverse drug reactions to a Selective Serotonin Reuptake Inhibitor (SSRI). Past conviction for murder, manslaughter or sexual assault. Regular use of amphetamine. From remote/inaccessible area.

Outcome results